Navigation Links
Creabilis Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board
Date:7/29/2013

has the potential to make a real difference to the lives of patients suffering from the condition. I look forward to working with the experienced Creabilis team to help achieve this goal."

Professor Praveen Anand, commenting on his appointment, said: "I'm delighted to join the Creabilis Scientific Board. Neuropathic pain is an area of significant unmet need. CT340, with its novel dual analgesic and anti-inflammatory mechanism of action and strong pre-clinical data has the potential to meet this need. Creabilis is at an exciting stage of its development, with CT327 in late stage development for chronic pruritus and CT340 IND-ready in neuropathic pain. Given the mechanistic similarities between pruritus and pain, I am excited to begin working with Creabilis to realise the potential of both CT340 and CT327."

Professor Jonathan Barker, Chair of the Scientific Advisory Board said: "Professors Anand and Yosipovitch bring further world-class expertise to an outstanding Advisory Board which will allow the Board to provide key scientific and clinical advice to Creabilis. It is a reflection of the quality of Creabilis' recent clinical data with CT327 in chronic pruritus, and pre-clinical data with CT340 in neuropathic pain, that we have been able to attract individuals of Gil and Praveen's calibre to our Scientific Advisory Board."  

About Creabilis SA

Creabilis is a late clinical stage European biotechnology company with a primary focus in chronic pruritus (itch), a debilitating symptom of many dermatological diseases with a negative impact on quality of life. Chronic pruritus is an area of significant unmet need, with no medicine currently approved for its treatment.

Creabilis has delivered positive Phase 2b results for CT327 in the treatment of pruritus in psoriasis patients. CT327 is a novel, first-in-class, topically delivered TrkA kinase inhibitor. CT327 was developed using
'/>"/>

SOURCE Creabilis SA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Creabilis Appoints Catherine Moukheibir to its Board of Directors
2. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
3. Alexander Proudfoot Appoints Executive Vice President for Life Sciences
4. KemPharm, Inc. Appoints Gordon K. "Rusty" Johnson as Chief Operating Officer and Chief Financial Officer
5. KaloBios Appoints Donald R. Joseph as Chief Legal Officer
6. Organovo Appoints Tamar D. Howson to Board of Directors
7. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
8. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
9. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
10. Envera Appoints Michael McErlean Fermentation Manager
11. WMIS Appoints Lisa Baird as Next Executive Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
(Date:12/15/2014)... 15, 2014 METTLER TOLEDO is ... tool, ParticleView V19 with PVM technology , ... particle vision and measurement tool continuously captures high-resolution ... ParticleView V19 then automatically prepares a report pairing ... size and concentration changes. This compelling blend of ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
(Date:12/13/2014)... 13, 2014 CanDiag, Inc., a University ... has changed its name to OncoTab, Inc. , ... where we are today,” said CEO and Chief Science ... applications beyond breast cancer diagnostics to include imaging and ... that evolution.” , Founded in 2011 by Dr. Mukherjee, ...
Breaking Biology Technology:CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... , ... that the European Investment Fund (EIF) has entered into ... be,managed by Karolinska Development and used to invest in ... EIF,has agreed to invest 26.7 M Euros in the ...
... ... a free webinar, “The Role of Process Analytical Technology (PAT) in Green Chemistry and ... ... of Process Analytical Technology (PAT) in Green Chemistry and Green Engineering Webinar on ...
... SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: OMER ) today ... 2009. For the three months ended September 30, 2009, Omeros reported ... compared to a net loss of $7.4 million, or $2.54 per ... ended September 30, 2009, the Company reported a net loss of ...
Cached Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:11/21/2014)... According to a new market research report ... Control, Intrusion Detection, Parking Management, Under Vehicle Inspection), End ... - Global Forecasts to 2020", published by MarketsandMarkets, The ... $25 Billion in 2014 and is expected to reach ... 8.69%. Browse 116 market data Tables and ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3
... This news release is available in German . ... is made up of a highly concentrated protein solution that imparts ... content the ocular lens must remain clear and transparent. To this ... thrown overboard the complex machinery present in all other cells of ...
... study led by scientists at the University of Miami (UM) ... complex circulation from the Mississippi River plume played a substantial ... the 2010 Deepwater Horizon incident. These findings provide new information ... Gulf of Mexico. The research, published in the Oct. 2013 ...
... use in vaccines and cancer medicines, enzymes for the ... already be produced on a large scale using biotechnology. ... making use of living cells or organisms. This involves ... protein to bacteria, yeasts, or cultures of animal or ...
Cached Biology News:A protein safeguards against cataracts 2A protein safeguards against cataracts 3New research illustrates Mississippi River's role 2Biomolecules for the production line 2Biomolecules for the production line 3
...
... is specifically designed for two-dimensional electrophoresis ... four proteins in this marker have ... pattern across a 2D gel. The ... Mol wt: 17,000-89,000 ...
... HEXALIGHT robot is based on PI's experience ... more than a decade. PI Hexapods were ... and antenna adjustments over wide ranges in ... degrees of freedom with 3 m minimum ...
... full length insert sequencing service for large ... fosmids. Agencourt utilizes unique library construction ... There are several features that allow Agencourt ... rapid turnaround including our patented magnetic bead-based ...
Biology Products: